Safety of Riluzole in Patients With Acute Spinal Cord Injury
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bizhan Aarabi, MD
University of Maryland Medical Center, Baltimore
Principal Investigator - Christopher Shaffery, MD
University of Virginia Health System, Charlottesville
Principal Investigator - Diana Chow, PhD
University of Houston, College of Pharmacy, Houston
Principal Investigator - James Guest, MD, PhD
University of Miami, Miami
Principal Investigator - James Harrop, MD
Thomas Jefferson University, Philadelphia
Principal Investigator - Michael Fehlings, MD, PhD
University of Toronto/Toronto Western Hospital, Toronto
Principal Investigator - Michele M Johnson, MD
the University of Houston/Memorial HermannHospital, Houston
Principal Investigator - Ralph Frankowski, PhD
The University of Texas School of Public Health, Houston
Principal Investigator - Robert G Grossman, MD
The Methodist Hospital Research Institute
Study Chair - Susan Harkema, PhD
University of Louisville, Louisville
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Toronto/toronto Western Hospital
Toronto, Ontario, Canada
- University of Miami
Miami, Florida, United States
- University of Louisville Health Sciences Center
Louisville, Kentucky, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- the Methodist Hospital
Houston, Texas, United States
- the University of Texas
Houston, Texas, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2010
- Primary completion
- 30 Jun 2011
- Completion
- 30 Apr 2012
- Last update posted
- 12 Sept 2017
- Registered enrollment
- 36
- Registry id
- NCT00876889
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.